New drug tested in people with liver issues

NCT ID NCT07165002

First seen Nov 01, 2025 · Last updated May 30, 2026 · Updated 26 times

Summary

This study looks at how a drug called LY3537031 is absorbed and cleared from the body in people with mild, moderate, or severe liver problems compared to healthy volunteers. About 32 adults will receive a single injection under the skin. The goal is to understand safety and drug levels, not to treat any condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Research Units Hungary

    RECRUITING

    Kistarcsa, H-243, Hungary

    Contact Phone: •••-•••-••••

    Contact

  • New Zealand Clinical Research Auckland

    RECRUITING

    Auckland, 1010, New Zealand

    Contact Phone: •••-•••-••••

    Contact

  • Summit Clinical Research, s.r.o. - Bratislava

    RECRUITING

    Bratislava, 831 01, Slovakia

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.